Michael J. Massare

Publications by Year

Research Areas

SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, Influenza Virus Research Studies, COVID-19 Clinical Research Studies, Viral gastroenteritis research and epidemiology

Most-Cited Works

• → SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice(2021)522 cited
• → Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate(2020)377 cited
• → Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice(2014)305 cited
• → NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge(2020)240 cited
• → Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats(2012)148 cited
• → Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination(2021)145 cited
• → Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology(2009)130 cited
• → Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice(2016)128 cited
• → Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins(2010)102 cited
• → An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization(2014)67 cited